全文获取类型
收费全文 | 11904篇 |
免费 | 667篇 |
国内免费 | 67篇 |
专业分类
耳鼻咽喉 | 146篇 |
儿科学 | 286篇 |
妇产科学 | 265篇 |
基础医学 | 1527篇 |
口腔科学 | 207篇 |
临床医学 | 1231篇 |
内科学 | 2617篇 |
皮肤病学 | 244篇 |
神经病学 | 1004篇 |
特种医学 | 282篇 |
外科学 | 1389篇 |
综合类 | 446篇 |
一般理论 | 12篇 |
预防医学 | 885篇 |
眼科学 | 256篇 |
药学 | 1097篇 |
中国医学 | 54篇 |
肿瘤学 | 690篇 |
出版年
2023年 | 56篇 |
2022年 | 118篇 |
2021年 | 236篇 |
2020年 | 111篇 |
2019年 | 158篇 |
2018年 | 202篇 |
2017年 | 172篇 |
2016年 | 197篇 |
2015年 | 385篇 |
2014年 | 486篇 |
2013年 | 549篇 |
2012年 | 696篇 |
2011年 | 811篇 |
2010年 | 373篇 |
2009年 | 470篇 |
2008年 | 630篇 |
2007年 | 755篇 |
2006年 | 648篇 |
2005年 | 594篇 |
2004年 | 589篇 |
2003年 | 509篇 |
2002年 | 513篇 |
2001年 | 237篇 |
2000年 | 191篇 |
1999年 | 172篇 |
1998年 | 108篇 |
1997年 | 103篇 |
1996年 | 95篇 |
1995年 | 83篇 |
1994年 | 90篇 |
1993年 | 94篇 |
1992年 | 154篇 |
1991年 | 161篇 |
1990年 | 122篇 |
1989年 | 142篇 |
1988年 | 135篇 |
1987年 | 125篇 |
1986年 | 127篇 |
1985年 | 81篇 |
1984年 | 90篇 |
1983年 | 74篇 |
1982年 | 83篇 |
1981年 | 65篇 |
1980年 | 56篇 |
1979年 | 55篇 |
1978年 | 48篇 |
1977年 | 47篇 |
1976年 | 44篇 |
1975年 | 65篇 |
1971年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
Urodynamic studies in the evaluation of young men presenting with lower urinary tract symptoms 总被引:1,自引:0,他引:1
AIM: To evaluate the usefulness of urodynamic study in young men with lower urinary tract symptoms (LUTS). METHODS: We reviewed the charts of 50 men with LUTS aged 50 years and below. Those with neurological diseases, urethral trauma or strictures were excluded. All underwent multichannel urodynamic studies (UDS). The pre- and post-UDS diagnoses and treatment modalities were compared. RESULTS: Mean age was 38.1 years (17-49). The main pre-UDS diagnoses included prostatitis in seven (14%), overactive bladder in seventeen (34%) and benign prostatic hyperplasia in nine (18%). Pre-UDS management ranged from anticholingeric agents for thirteen (26%), alpha-adrenergic antagonists for nine (18%), antibiotics for six (12%). Abnormal UDS were noted in 36 (72%), including detrusor overactivity in 9 (18%), detrusor underactivity/acontractility in 5 (10%) and bladder outlet obstruction in 21 (42%). Fourteen (28%) had primary bladder neck dysfunction and five (10%) had benign prostatic hyperplasia. Post-UDS management included anticholingeric agents for ten (26%), alpha-adrenergic antagonists for seventeen (34%), catheterization for four (10%), behavioral therapy for three (6%), surgery for three (6%). None were prescribed antibiotics. Following UDS, the diagnosis had to be updated in 40 (80%) and concomitant change in management was required in 34 (68%). CONCLUSION: Young men presenting with LUTS have different underlying etiologies. Clinical diagnosis and treatment are often empiric and inaccurate. Urodynamic study is useful in the evaluation of this group of patients as it aids in arriving at an accurate diagnosis and guides treatment therapy. 相似文献
7.
Regina Gershkovich David Sacks Abraham Chlibovsky Sonia Yudaev Asher Korzets 《Nephrology, dialysis, transplantation》2006,21(2):539-540
Case report A 28-year-old female patient was admitted because of painlessmacroscopic haematuria. Past history included severe mentalretardation and nystagmus. At age 17, a computed tomography(CT) scan of the brain showed an absent cerebellar vermis andcerebellar hypoplasia. There was no 相似文献
8.
Abraham Nudelman Yitschak Binnes Naomi Shmueli-Broide Yael Odessa J. Paul Hieble Anthony C. Sulpizio 《Archiv der Pharmazie》1996,329(3):125-132
Vinylogous (Groups III and V ) and acetylenologous (Group IV ) analogs of the classical β-adrenergic agents — stimulants and blockers — were prepared in order to evaluate the effect of degree of saturation, position of unsaturation and rigidity of the chain linking the aromatic ring and the amino containing functional group on biological activity. Derivatives from Group III , which represent 4-aryl-3-butenyl-2-ol-amine analogs of Group II , retained β1-adrenoceptor antagonist activity albeit substantially less potent (50–200-fold) than that possessed by their aryloxy counterparts. Consistent with the SAR for Group II compounds, substitution at position 2 of the aromatic ring yielded the most potent antagonists ( 5a, 5d, 5g ), with KB's ranging from 73–93 nM while 3,4-dichloro substitution ( 5e ) markedly reduced antagonist potency (KB = 2,400 nM). Agonist activity was also noted for 5b and 5d , suggesting that these compounds may be best classified as partial agonists. Representatives from Groups IV and V were inactive as antagonists at the β1-adrenoceptor confirming the importance of the spatial relationship between the hydroxyl and the amino nitrogen. 相似文献
9.
M L Schwartzman P Martasek A R Rios R D Levere K Solangi A I Goodman N G Abraham 《Kidney international》1990,37(1):94-99
Cytochrome P450-dependent arachidonic acid metabolism in human kidney cortex from several postmortem subjects has been characterized. Using HPLC and GC/MS, four cytochrome P450-arachidonic acid metabolites were tentatively but not unequivocally identified as epoxyeicosatrienoic acid (EET), dihydroxyeicosatrienoic acid (DHT) and 19- and 20-hydroxyeicosatetraenoic acids, suggesting the involvement of two major cytochrome P450 enzymes, epoxygenase and omega/omega-1 hydroxylases. This pattern of metabolism was similar to that found in rabbit and rat kidneys. The formation of these metabolites was dependent on the presence of NADPH and inhibited by IgG of NADPH-cytochrome P450 (c) reductase. Immunologic studies of renal cytochrome P450 epoxygenase demonstrated that antibodies prepared against human-purified hepatic cytochrome P450 epoxygenase recognized renal enzyme protein and inhibited the enzyme activity by 92%. In contrast, control immunoglobulin did not inhibit renal cytochrome P450 epoxygenase. Antibody inhibition of renal cytochrome P450 epoxygenase demonstrated a degree of conservation of both enzyme proteins between liver and kidney. Antibodies against lauric acid omega/omega-1 hydroxylases (P450 omega) inhibited the formation of omega/omega-1 hydroxylase products, 19- and 20-HETEs. Identical qualitative patterns of arachidonic acid metabolites were observed in all cortical microsomes studied. Interindividual variations were observed in the cytochrome P450-dependent arachidonic acid metabolism, and the activities ranged from 0.031 to 5.027 nmol arachidonic acid converted/mg protein/30 min. which is about a 150-fold difference. However, when the specific activities for total cytochrome P450-dependent arachidonic acid metabolism were calculated, two separate groups could be distinguished, high and low metabolizers of arachidonic acid.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
10.